APOL1 variant risk may extend to poorer outcomes from SARS-CoV-2 infection

By | November 4, 2021
Now, a new study published on the medRxiv* preprint server tests the hypothesis that adverse COVID-19 outcomes are associated with the variants of the APOL1 gene.